Brightsurf Science News & Current Events

January 28, 2017
Experts predict melanoma death rates will fall by 2050
By 2050 the death rates from malignant melanoma will have decreased from their current levels but the numbers of people dying from the disease will have increased due to the aging of populations.

Delays in access to cancer medicines and unjustifiable price rises disadvantage patients
Cancer patients need speedy access to new drugs and fair prices for old ones, but in many cases they are getting neither, according to studies presented at ECC2017 by researchers from the UK and Germany.

The immunotherapy, pembrolizumab, is active against mucosal melanoma tumors
Clinical trials of a new immunotherapy, pembrolizumab, have shown that it prolongs life significantly for patients with bladder cancer and is active against a rare sub-type of melanoma, called mucosal melanoma.

Researchers identify earliest known protein needed for cell division
Researchers from three US universities have identified, using roundworms, the earliest-acting protein known to duplicate the centriole, a tiny cylinder-shaped structure that is a key component of the machinery that organizes cell division in animals.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.